Latest Actos Stories
Drug makers Takeda and Eli Lilly lost a bid to have the Actos trial thrown out.
Takeda Stresses Continued Confidence in ACTOS DEERFIELD, Ill. and OSAKA, Japan, Sept.
The Firm is evaluating Actos lawsuits on behalf of individuals who developed bladder cancer, allegedly due to long-term use of the Type 2 diabetes drug. New
In light of the latest development in Actos litigation, The Law Office of Melinda J. Helbock A.P.C.
No overall statistically significant increased risk of bladder cancer in patients ever exposed to pioglitazone in a completed 10-year epidemiological study OSAKA, Japan, Aug.
MT Services LLC informs plaintiffs on ongoing cases with Takeda Pharmaceutical, manufacturer of Actos (Pioglitazone hydrochloride) diabetes drug, seeking post-trial motions to lower $9Bil.
Takeda Pharmaceuticals Co. and Eli Lilly & Co.
The Firm is evaluating Actos lawsuits on behalf of long-term users of the Type 2 diabetes medication who allegedly developed bladder cancer due to Actos. (PRWEB)
Pre-Settlement Case Funding Firm announces new program focus for plaintiffs of Byetta, as well as Actos, Januvia, and Victoza cases. LOS ANGELES, June 27, 2014 /PRNewswire/ -- Legal-Bay
In light of Blue Cross and Blue Shield of Massachusetts’ recent Actos lawsuit, Flood Law Group announces it is investigating potential Actos claims. Washington,
- The act of sweetening by admixture of some saccharine substance.